Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 91NIH 32INDUSTRY 15NETWORK 10UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

sintilimab 1Irinotecan 1HMPL-013 1Fecal Microbiota Transplantation 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Colonic Neoplasms × Irinotecan × Clear all
NCT03545711 2018-08-06

Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

ChineseAMS

Phase 1/2 Unknown
42 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡